100 related articles for article (PubMed ID: 9474188)
1. Low p27 expression predicts poor disease-free survival in patients with prostate cancer.
Yang RM; Naitoh J; Murphy M; Wang HJ; Phillipson J; deKernion JB; Loda M; Reiter RE
J Urol; 1998 Mar; 159(3):941-5. PubMed ID: 9474188
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer?
Boxler S; Djonov V; Kessler TM; Hlushchuk R; Bachmann LM; Held U; Markwalder R; Thalmann GN
Am J Pathol; 2010 Nov; 177(5):2216-24. PubMed ID: 20889560
[TBL] [Abstract][Full Text] [Related]
3. FGFR1 and WT1 are markers of human prostate cancer progression.
Devilard E; Bladou F; Ramuz O; Karsenty G; Dalès JP; Gravis G; Nguyen C; Bertucci F; Xerri L; Birnbaum D
BMC Cancer; 2006 Nov; 6():272. PubMed ID: 17137506
[TBL] [Abstract][Full Text] [Related]
4. Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors.
Orozco-Moreno M; Visser EA; Hodgson K; Hipgrave Ederveen AL; Bastian K; Goode EA; Öztürk Ö; Pijnenborg JFA; Eerden N; Moons SJ; Rossing E; Wang N; de Haan N; Büll C; Boltje TJ; Munkley J
Glycobiology; 2023 Dec; 33(12):1155-1171. PubMed ID: 37847613
[TBL] [Abstract][Full Text] [Related]
5. Role of Genetic Variations in
Híveš M; Jurečeková J; Kliment J; Grendár M; Kaplán P; Dušenka R; Evin D; Vilčková M; Holečková KH; Sivoňová MK
Cancer Genomics Proteomics; 2022; 19(3):362-371. PubMed ID: 35430569
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics analysis reveals the
Hsiao TH; Chiu YC; Shao YJ
Transl Cancer Res; 2019 Aug; 8(4):1279-1288. PubMed ID: 35116870
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive Effects of Licorice and Its Components.
Bode AM; Dong Z
Curr Pharmacol Rep; 2015; 1(1):60-71. PubMed ID: 32226725
[TBL] [Abstract][Full Text] [Related]
8.
Faisal FA; Murali S; Kaur H; Vidotto T; Guedes LB; Salles DC; Kothari V; Tosoian JJ; Han S; Hovelson DH; Hu K; Spratt DE; Baras AS; Tomlins SA; Schaeffer EM; Lotan TL
Clin Cancer Res; 2020 Jun; 26(11):2595-2602. PubMed ID: 31969336
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-130b Contributes to Risk of Poor Prognosis and Racial Disparity in African-American Prostate Cancer.
Hashimoto Y; Shiina M; Dasgupta P; Kulkarni P; Kato T; Wong RK; Tanaka Y; Shahryari V; Maekawa S; Yamamura S; Saini S; Deng G; Tabatabai ZL; Majid S; Dahiya R
Cancer Prev Res (Phila); 2019 Sep; 12(9):585-598. PubMed ID: 31266828
[TBL] [Abstract][Full Text] [Related]
10. Nonmonotonic Pathway Gene Expression Analysis Reveals Oncogenic Role of p27/Kip1 at Intermediate Dose.
Nguyen HH; Tilton SC; Kemp CJ; Song M
Cancer Inform; 2017; 16():1176935117740132. PubMed ID: 29162974
[TBL] [Abstract][Full Text] [Related]
11. 2',4'-dihydroxychalcone, a flavonoid isolated from
Sheng Y; Zou M; Wang Y; Li Q
Oncol Lett; 2015 Dec; 10(6):3737-3741. PubMed ID: 26788200
[TBL] [Abstract][Full Text] [Related]
12. Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.
Kluth M; Ahrary R; Hube-Magg C; Ahmed M; Volta H; Schwemin C; Steurer S; Wittmer C; Wilczak W; Burandt E; Krech T; Adam M; Michl U; Heinzer H; Salomon G; Graefen M; Koop C; Minner S; Simon R; Sauter G; Schlomm T
Oncotarget; 2015 Sep; 6(29):27966-79. PubMed ID: 26293672
[TBL] [Abstract][Full Text] [Related]
13. EPMA position paper in cancer: current overview and future perspectives.
Grech G; Zhan X; Yoo BC; Bubnov R; Hagan S; Danesi R; Vittadini G; Desiderio DM
EPMA J; 2015; 6(1):9. PubMed ID: 25908947
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.
Sequeiros T; García M; Montes M; Oliván M; Rigau M; Colás E; de Torres I; Morote J; Reventós J; Doll A
Biomed Res Int; 2013; 2013():283635. PubMed ID: 24371818
[TBL] [Abstract][Full Text] [Related]
15. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis.
Sirma H; Broemel M; Stumm L; Tsourlakis T; Steurer S; Tennstedt P; Salomon G; Michl U; Haese A; Simon R; Sauter G; Schlomm T; Minner S
Oncol Lett; 2013 Nov; 6(5):1245-1252. PubMed ID: 24179503
[TBL] [Abstract][Full Text] [Related]
16. Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.
Su S; Minges JT; Grossman G; Blackwelder AJ; Mohler JL; Wilson EM
J Biol Chem; 2013 Aug; 288(34):24809-24. PubMed ID: 23853093
[TBL] [Abstract][Full Text] [Related]
17. The yin-yang of DNA damage response: roles in tumorigenesis and cellular senescence.
Li X; Xu H; Xu C; Lin M; Song X; Yi F; Feng Y; Coughlan KA; Cho WC; Kim SS; Cao L
Int J Mol Sci; 2013 Jan; 14(2):2431-48. PubMed ID: 23354477
[TBL] [Abstract][Full Text] [Related]
18. Doxycycline regulated induction of AKT in murine prostate drives proliferation independently of p27 cyclin dependent kinase inhibitor downregulation.
Wang H; Xu Y; Fang Z; Chen S; Balk SP; Yuan X
PLoS One; 2012; 7(7):e41330. PubMed ID: 22844460
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of prostate cancer.
Chin SP; Dickinson JL; Holloway AF
Clin Epigenetics; 2011 Aug; 2(2):151-69. PubMed ID: 22704335
[TBL] [Abstract][Full Text] [Related]
20. Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer.
Vlachostergios PJ; Karasavvidou F; Kakkas G; Kapatou K; Gioulbasanis I; Daliani DD; Moutzouris G; Papandreou CN
J Negat Results Biomed; 2012 Jan; 11(1):2. PubMed ID: 22221586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
